Metabolic syndrome and drug discontinuation in schizophrenia: a randomized trial comparing aripiprazole olanzapine and haloperidol.
about
Changes in BMI in hospitalized patients during treatment with antipsychotics, depending on gender and other factors.First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in VitroLong-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis.Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis
P2860
Metabolic syndrome and drug discontinuation in schizophrenia: a randomized trial comparing aripiprazole olanzapine and haloperidol.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Metabolic syndrome and drug di ...... le olanzapine and haloperidol.
@en
Metabolic syndrome and drug di ...... le olanzapine and haloperidol.
@nl
type
label
Metabolic syndrome and drug di ...... le olanzapine and haloperidol.
@en
Metabolic syndrome and drug di ...... le olanzapine and haloperidol.
@nl
prefLabel
Metabolic syndrome and drug di ...... le olanzapine and haloperidol.
@en
Metabolic syndrome and drug di ...... le olanzapine and haloperidol.
@nl
P2093
P2860
P356
P1476
Metabolic syndrome and drug di ...... le olanzapine and haloperidol.
@en
P2093
A Parabiaghi
B D'Avanzo
GiSAS study group
M Tettamanti
P2860
P356
10.1111/ACPS.12468
P407
P577
2015-08-07T00:00:00Z